APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Gastrointestinal Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global OTC Gastrointestinal Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025180 pages

Choose your research edition.

Industry ResearchOTC Gastrointestinal Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Gastrointestinal Products Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal OTC Gastrointestinal Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Gastrointestinal Products Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Gastrointestinal Products Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global OTC Gastrointestinal Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for OTC Gastrointestinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Gastrointestinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Gastrointestinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for OTC Gastrointestinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Gastrointestinal Products include Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global OTC Gastrointestinal Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Gastrointestinal Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Gastrointestinal Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the OTC Gastrointestinal Products market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Gastrointestinal Products Segment by Company

Novartis

Merck

Pfizer

GlaxoSmithKline

Bayer

Bristol-Myers Squibb

OTC Gastrointestinal Products Segment by Type

H2 Receptor Antagonists

Proton Pump Inhibitors (PPIs)

OTC Gastrointestinal Products Segment by Application

E-Commerce

Retail Stores

Drug Stores

Hospital Pharmacies

OTC Gastrointestinal Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Gastrointestinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Gastrointestinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Gastrointestinal Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the OTC Gastrointestinal Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of OTC Gastrointestinal Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of OTC Gastrointestinal Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of OTC Gastrointestinal Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. OTC Gastrointestinal Products Industry Trends Table 2. OTC Gastrointestinal Products Industry Drivers Table 3. OTC Gastrointestinal Products Industry Opportunities and Challenges Table 4. OTC Gastrointestinal Products Industry Restraints Table 5. Global OTC Gastrointestinal Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global OTC Gastrointestinal Products Revenue Market Share by Manufacturers (2021-2026) Table 7. Global OTC Gastrointestinal Products Sales by Manufacturers (k units) & (2021-2026) Table 8. Global OTC Gastrointestinal Products Sales Market Share by Manufacturers Table 9. Global OTC Gastrointestinal Products Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global OTC Gastrointestinal Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global OTC Gastrointestinal Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global OTC Gastrointestinal Products Manufacturers, Product Type & Application Table 13. Global OTC Gastrointestinal Products Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global OTC Gastrointestinal Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of H2 Receptor Antagonists Table 17. Major Manufacturers of Proton Pump Inhibitors (PPIs) Table 18. Global OTC Gastrointestinal Products Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global OTC Gastrointestinal Products Sales by Type (2021-2026) & (k units) Table 20. Global OTC Gastrointestinal Products Sales by Type (2027-2032) & (k units) Table 21. Global OTC Gastrointestinal Products Sales Market Share by Type (2021-2026) Table 22. Global OTC Gastrointestinal Products Sales Market Share by Type (2027-2032) Table 23. Global OTC Gastrointestinal Products Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global OTC Gastrointestinal Products Revenue by Type (2021-2026) & (k units) Table 25. Global OTC Gastrointestinal Products Revenue by Type (2027-2032) & (k units) Table 26. Global OTC Gastrointestinal Products Revenue Market Share by Type (2021-2026) Table 27. Global OTC Gastrointestinal Products Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of E-Commerce Table 29. Major Manufacturers of Retail Stores Table 30. Major Manufacturers of Drug Stores Table 31. Major Manufacturers of Hospital Pharmacies Table 32. Global OTC Gastrointestinal Products Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global OTC Gastrointestinal Products Sales by Application (2021-2026) & (k units) Table 34. Global OTC Gastrointestinal Products Sales by Application (2027-2032) & (k units) Table 35. Global OTC Gastrointestinal Products Sales Market Share by Application (2021-2026) Table 36. Global OTC Gastrointestinal Products Sales Market Share by Application (2027-2032) Table 37. Global OTC Gastrointestinal Products Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global OTC Gastrointestinal Products Revenue by Application (2021-2026) & (k units) Table 39. Global OTC Gastrointestinal Products Revenue by Application (2027-2032) & (k units) Table 40. Global OTC Gastrointestinal Products Revenue Market Share by Application (2021-2026) Table 41. Global OTC Gastrointestinal Products Revenue Market Share by Application (2027-2032) Table 42. Global OTC Gastrointestinal Products Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global OTC Gastrointestinal Products Sales by Region (2021-2026) & (k units) Table 44. Global OTC Gastrointestinal Products Sales Market Share by Region (2021-2026) Table 45. Global OTC Gastrointestinal Products Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global OTC Gastrointestinal Products Sales Forecasted Market Share by Region (2027-2032) Table 47. North America OTC Gastrointestinal Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America OTC Gastrointestinal Products Sales by Country (2021-2026) & (k units) Table 49. North America OTC Gastrointestinal Products Sales by Country (2027-2032) & (k units) Table 50. Europe OTC Gastrointestinal Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe OTC Gastrointestinal Products Sales by Country (2021-2026) & (k units) Table 52. Europe OTC Gastrointestinal Products Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific OTC Gastrointestinal Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific OTC Gastrointestinal Products Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific OTC Gastrointestinal Products Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa OTC Gastrointestinal Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa OTC Gastrointestinal Products Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa OTC Gastrointestinal Products Sales by Country (2027-2032) & (k units) Table 59. Global OTC Gastrointestinal Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global OTC Gastrointestinal Products Revenue by Region (2021-2026) & (US$ Million) Table 61. Global OTC Gastrointestinal Products Revenue by Region (2027-2032) & (US$ Million) Table 62. Global OTC Gastrointestinal Products Revenue Market Share by Region (2021-2026) Table 63. Global OTC Gastrointestinal Products Revenue Market Share by Region (2027-2032) Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis OTC Gastrointestinal Products Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Novartis OTC Gastrointestinal Products Product Portfolio Table 68. Novartis Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck OTC Gastrointestinal Products Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck OTC Gastrointestinal Products Product Portfolio Table 73. Merck Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer OTC Gastrointestinal Products Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer OTC Gastrointestinal Products Product Portfolio Table 78. Pfizer Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline OTC Gastrointestinal Products Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline OTC Gastrointestinal Products Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. Bayer Company Information Table 85. Bayer Business Overview Table 86. Bayer OTC Gastrointestinal Products Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bayer OTC Gastrointestinal Products Product Portfolio Table 88. Bayer Recent Development Table 89. Bristol-Myers Squibb Company Information Table 90. Bristol-Myers Squibb Business Overview Table 91. Bristol-Myers Squibb OTC Gastrointestinal Products Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Bristol-Myers Squibb OTC Gastrointestinal Products Product Portfolio Table 93. Bristol-Myers Squibb Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. OTC Gastrointestinal Products Distributors List Table 97. OTC Gastrointestinal Products Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. OTC Gastrointestinal Products Product Image Figure 2. Global OTC Gastrointestinal Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Gastrointestinal Products Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Gastrointestinal Products Sales (2021-2032) & (k units) Figure 5. Global OTC Gastrointestinal Products Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 OTC Gastrointestinal Products Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. H2 Receptor Antagonists Image Figure 9. Proton Pump Inhibitors (PPIs) Image Figure 10. Global OTC Gastrointestinal Products Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global OTC Gastrointestinal Products Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global OTC Gastrointestinal Products Sales Market Share by Type (2021-2032) Figure 13. Global OTC Gastrointestinal Products Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global OTC Gastrointestinal Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global OTC Gastrointestinal Products Revenue Market Share by Type (2021-2032) Figure 16. E-Commerce Image Figure 17. Retail Stores Image Figure 18. Drug Stores Image Figure 19. Hospital Pharmacies Image Figure 20. Global OTC Gastrointestinal Products Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global OTC Gastrointestinal Products Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global OTC Gastrointestinal Products Sales Market Share by Application (2021-2032) Figure 23. Global OTC Gastrointestinal Products Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global OTC Gastrointestinal Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global OTC Gastrointestinal Products Revenue Market Share by Application (2021-2032) Figure 26. North America OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America OTC Gastrointestinal Products Sales Market Share by Country (2021-2032) Figure 28. U.S. OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe OTC Gastrointestinal Products Sales Market Share by Country (2021-2032) Figure 33. Germany OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 34. France OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Country (2021-2032) Figure 40. China OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 44. India OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Country (2021-2032) Figure 48. Brazil OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile OTC Gastrointestinal Products Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global OTC Gastrointestinal Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global OTC Gastrointestinal Products Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America OTC Gastrointestinal Products Revenue (2021-2032) & (US$ Million) Figure 59. North America OTC Gastrointestinal Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe OTC Gastrointestinal Products Revenue (2021-2032) & (US$ Million) Figure 61. Europe OTC Gastrointestinal Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific OTC Gastrointestinal Products Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific OTC Gastrointestinal Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa OTC Gastrointestinal Products Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa OTC Gastrointestinal Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. OTC Gastrointestinal Products Value Chain Figure 67. Manufacturing Cost Structure Figure 68. OTC Gastrointestinal Products Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • H2 Receptor Antagonists
  • Proton Pump Inhibitors (PPIs)
Applications
  • E-Commerce
  • Retail Stores
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Gastrointestinal Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Gastrointestinal Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global OTC Gastrointestinal Products Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global OTC Gastrointestinal Products Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global OTC Gastrointestinal Products Market Dynamics
  1. 2.1 OTC Gastrointestinal Products Industry Trends
  2. 2.2 OTC Gastrointestinal Products Industry Drivers
  3. 2.3 OTC Gastrointestinal Products Industry Opportunities and Challenges
  4. 2.4 OTC Gastrointestinal Products Industry Restraints
3 OTC Gastrointestinal Products Market by Manufacturers
  1. 3.1 Global OTC Gastrointestinal Products Revenue by Manufacturers (2021-2026)
  2. 3.2 Global OTC Gastrointestinal Products Sales by Manufacturers (2021-2026)
  3. 3.3 Global OTC Gastrointestinal Products Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global OTC Gastrointestinal Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global OTC Gastrointestinal Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global OTC Gastrointestinal Products Manufacturers, Product Type & Application
  7. 3.7 Global OTC Gastrointestinal Products Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global OTC Gastrointestinal Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 OTC Gastrointestinal Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 OTC Gastrointestinal Products Tier 1, Tier 2, and Tier 3
4 OTC Gastrointestinal Products Market by Type
  1. 4.1 OTC Gastrointestinal Products Type Introduction
  2. 4.1.1 H2 Receptor Antagonists
  3. 4.1.2 Proton Pump Inhibitors (PPIs)
  4. 4.2 Global OTC Gastrointestinal Products Sales by Type
  5. 4.2.1 Global OTC Gastrointestinal Products Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global OTC Gastrointestinal Products Sales by Type (2021-2032)
  7. 4.2.3 Global OTC Gastrointestinal Products Sales Market Share by Type (2021-2032)
  8. 4.3 Global OTC Gastrointestinal Products Revenue by Type
  9. 4.3.1 Global OTC Gastrointestinal Products Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global OTC Gastrointestinal Products Revenue by Type (2021-2032)
  11. 4.3.3 Global OTC Gastrointestinal Products Revenue Market Share by Type (2021-2032)
5 OTC Gastrointestinal Products Market by Application
  1. 5.1 OTC Gastrointestinal Products Application Introduction
  2. 5.1.1 E-Commerce
  3. 5.1.2 Retail Stores
  4. 5.1.3 Drug Stores
  5. 5.1.4 Hospital Pharmacies
  6. 5.2 Global OTC Gastrointestinal Products Sales by Application
  7. 5.2.1 Global OTC Gastrointestinal Products Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global OTC Gastrointestinal Products Sales by Application (2021-2032)
  9. 5.2.3 Global OTC Gastrointestinal Products Sales Market Share by Application (2021-2032)
  10. 5.3 Global OTC Gastrointestinal Products Revenue by Application
  11. 5.3.1 Global OTC Gastrointestinal Products Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global OTC Gastrointestinal Products Revenue by Application (2021-2032)
  13. 5.3.3 Global OTC Gastrointestinal Products Revenue Market Share by Application (2021-2032)
6 Global OTC Gastrointestinal Products Sales by Region
  1. 6.1 Global OTC Gastrointestinal Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Gastrointestinal Products Sales by Region (2021-2032)
  3. 6.2.1 Global OTC Gastrointestinal Products Sales by Region (2021-2026)
  4. 6.2.2 Global OTC Gastrointestinal Products Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Gastrointestinal Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America OTC Gastrointestinal Products Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe OTC Gastrointestinal Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe OTC Gastrointestinal Products Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific OTC Gastrointestinal Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific OTC Gastrointestinal Products Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa OTC Gastrointestinal Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa OTC Gastrointestinal Products Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global OTC Gastrointestinal Products Revenue by Region
  1. 7.1 Global OTC Gastrointestinal Products Revenue by Region
  2. 7.1.1 Global OTC Gastrointestinal Products Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global OTC Gastrointestinal Products Revenue by Region (2021-2026)
  4. 7.1.3 Global OTC Gastrointestinal Products Revenue by Region (2027-2032)
  5. 7.1.4 Global OTC Gastrointestinal Products Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America OTC Gastrointestinal Products Revenue (2021-2032)
  8. 7.2.2 North America OTC Gastrointestinal Products Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe OTC Gastrointestinal Products Revenue (2021-2032)
  11. 7.3.2 Europe OTC Gastrointestinal Products Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific OTC Gastrointestinal Products Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific OTC Gastrointestinal Products Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa OTC Gastrointestinal Products Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa OTC Gastrointestinal Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis OTC Gastrointestinal Products Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis OTC Gastrointestinal Products Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck OTC Gastrointestinal Products Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck OTC Gastrointestinal Products Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer OTC Gastrointestinal Products Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer OTC Gastrointestinal Products Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline OTC Gastrointestinal Products Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline OTC Gastrointestinal Products Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer OTC Gastrointestinal Products Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer OTC Gastrointestinal Products Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 Bristol-Myers Squibb
  32. 8.6.1 Bristol-Myers Squibb Company Information
  33. 8.6.2 Bristol-Myers Squibb Business Overview
  34. 8.6.3 Bristol-Myers Squibb OTC Gastrointestinal Products Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Product Portfolio
  36. 8.6.5 Bristol-Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 OTC Gastrointestinal Products Value Chain Analysis
  2. 9.1.1 OTC Gastrointestinal Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 OTC Gastrointestinal Products Production Mode & Process
  6. 9.2 OTC Gastrointestinal Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 OTC Gastrointestinal Products Distributors
  9. 9.2.3 OTC Gastrointestinal Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst